Health·2,841 stories
Ollin Biosciences has raised a $330 million Series B, co-led by TCGX and ARCH Venture Partners, to fund a Phase 3 trial of its therapy for two leading causes of vision loss in millions of Americans.
Sri Lanka faces a surging dengue outbreak with 47,530 cases and 29 deaths as the government deploys a military-led unit to manage the crisis amid strained hospitals and environmental conditions fuelin
NPR journalist Manoush Zomorodi helped lead a peer-reviewed study of 20,000 Americans, published in the British Journal of Sports Medicine, finding that hourly movement breaks are feasible in everyday
LivaNova's VITARIA vagus nerve stimulator, which the FDA designated as a breakthrough device for heart failure, won't reach the U.S. market despite an adaptive trial co-designed with the agency to ena
Researchers used plate tectonic simulations to identify the Alps and Pyrenees as strong natural hydrogen exploration sites, finding mountain-building processes brought mantle rocks to the surface at t
A Columbia University study of over 11,000 US office workers found that five-minute walking breaks every hour delivered the biggest gains in mood, alertness, and productivity — and were the most reali
Researchers at Curtin University have revised the age of Western Australia's North Pole Dome crater to 3.02 billion years old using direct mineral dating inside shatter cones, a claim that—if confirme
Stanford professor Kevin Schulman argues the FDA should encourage independent, accredited laboratory testing of generic drugs to address persistent quality problems that drive over 60% of shortages an
Neuroscience research shows pregnancy and parenthood trigger lasting structural brain changes in both mothers and fathers — from grey matter pruning to a default mode network remodeled for caregiving
SpaceX successfully launched a demo of its secretive Starfall cargo delivery system to low Earth orbit aboard a Falcon 9, advancing a service designed to return space-manufactured pharmaceuticals and
The Justice Department charged 455 people in a two-week health care fraud crackdown alleging more than $6.5 billion in false claims, with one Florida cardiologist's $89 million scheme — in which a tee
University of Pittsburgh researchers identified the biological reason H5N1 bird flu caused severe udder infections rather than respiratory illness in U.S. dairy cattle, finding the virus binds only to
Giving an individual special access to an experimental obesity drug is highly unusual.
Researchers are pinpointing why a minority of stroke survivors make extraordinary recoveries — genetics, pre-stroke brain health and brain's own rewiring — and racing to translate those advantages int
Pfizer disclosed that its experimental lung cancer drug sigvotatug vedotin failed to outperform the 1996 chemotherapy docetaxel in a clinical trial, while the FDA announced a pilot program to accelera
Eli Lilly and the FDA allowed a single individual to receive the pharma company's experimental obesity drug retatrutide through the agency's compassionate use program, an extraordinary pre-approval ac
OpenEvidence is set to integrate an FDA-cleared AI tool that detects heart disease from EKGs, developed by researcher Pierre Elias, a 2020 STAT Wunderkind now commercializing his academic work.
Austin-based Minicircle is preparing to sell an injectable klotho gene therapy at offshore clinics in Honduras, the Bahamas, and Panama within six months — sidestepping FDA approval and rigorous clini
Digital health company Cadence raised $100 million led by Spark Capital at a $1.23 billion valuation, betting on AI automation to scale chronic disease management even as its remote-monitoring billing
New research finds that multidrug-resistant bacteria from hospitals also resist the widely used weedkiller glyphosate, suggesting agricultural herbicides may be unintentionally selecting for dangerous
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.